Halozyme Therapeutics, Inc. (HALO)
68.72
+1.28
(+1.89%)
USD |
NASDAQ |
May 19, 16:00
68.72
0.00 (0.00%)
After-Hours: 18:08
Halozyme Therapeutics EPS Diluted (TTM) : 2.780 for March 31, 2026
EPS Diluted (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (TTM) Benchmarks
| Vertex Pharmaceuticals, Inc. | 16.87 |
| Agenus, Inc. | 1.670 |
| Inovio Pharmaceuticals, Inc. | -1.708 |
| Curis, Inc. | -1.194 |
| LadRx Corp. | -5.041 |